WASHINGTON (dpa-AFX) – Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted a positive opinion, recommending mark…
CHMP Issues Positive Opinion On Novo Nordisk’s Wegovy 7.2 Mg For Obesity
Source: Finanznachrichten.de
Read Full Story →
